Connect with us

Hi, what are you looking for?

Europe

Pfizer CEO pulls out of testifying to EU Parliament COVID panel

Pfizer Chief Executive Albert Bourla has pulled out of an appointment to testify before the European Parliament’s special committee on COVID-19, at which he was expected to face tough questions on how secretive vaccine deals were struck.

The decision follows an audit report into the EU’s vaccine procurement strategy published earlier in the month that raised new questions about contact between Bourla and European Commission President Ursula von der Leyen that preceded a multibillion-euro vaccine contract.

The head of the U.S. pharmaceutical giant, the largest supplier of COVID-19 vaccines to the EU, was scheduled to appear before the panel on October 10. The committee is meeting with key officials involved in the EU’s vaccine procurement process to draw lessons on how to respond to future pandemics. Other pharmaceutical executives have addressed the committee, including the CEO of Moderna and senior officials from AstraZeneca and Sanofi.

The committee’s chair, Belgian MEP Kathleen Van Brempt, told POLITICO she “deeply regrets” the decision taken by Pfizer.

After a visit to BioNTech’s headquarters last week, Van Brempt had said in a written statement that she looked forward to discussions “with other CEOs” including “Mr. Albert Bourla, the CEO of Pfizer” on October 10.

The report, by the European Court of Auditors, found that von der Leyen had been directly involved in preliminary negotiations for the EU’s biggest vaccine contract, for up to 1.8 billion doses of the BioNTech/Pfizer vaccine, which was concluded in May 2021. This was a departure from the negotiating procedure followed with other contracts, where a joint negotiating team made up of officials from the Commission and member countries conducted exploratory talks.

The EU watchdog also noted that the Commission refused to provide records of the discussions with Pfizer, either in the form of minutes, names of experts consulted, agreed terms, or other evidence.

Already in 2021, the New York Times reported on the seemingly-cozy relationship between Bourla and von der Leyen, with the two exchanging text messages in the run-up to the deal.

Contacted by POLITICO, a spokesperson for Pfizer said the company’s president of international development markets, Janine Small, would attend the committee hearing. “She has been identified as best placed to support the committee in meeting their objectives,” the spokesperson said.

Click to comment

Leave a Reply

Your email address will not be published.

You May Also Like

Foreign Policy

BERLIN — The German government gave a piece of advice to China on Monday as the country faces historic protests against its rigid zero-COVID...

Europe

Cardiovascular disease (CVD) — often regarded as the ‘silent pandemic’ — is the leading cause of death worldwide. In 2019 alone, it was responsible...

Europe

Ukrainian President Volodymyr Zelenskyy on Saturday received top Western officials as he officially launched a new food initiative to export grain to Africa. Zelenskyy hosted...

Europe

Crowds are protesting in China’s Xinjiang region against COVID-19 lockdown measures. Videos from the Xinjiang capital Urumqi published online — and verified by Reuters...

Europe

Eurozone finance ministers on Friday elected Pierre Gramegna, a former finance minister of Luxembourg, to lead the European Stability Mechanism (ESM). The election caps...

Elections

PARIS — French President Emmanuel Macron said Friday he believes he is not “at the heart of the investigation” into the role played by...

Europe

Hungary has failed to adopt promised rule-of-law reforms, the European Commission decided Wednesday, putting billions in EU cash in jeopardy for the country.  The...

Energy

Press play to listen to this article Voiced by artificial intelligence. CHIȘINĂU — At the peak of his power, Russian President Vladimir Putin thought he...